AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Treating Relapse After CAR T Cell Therapy in Lymphoma
The challenges and options for treating relapse after CAR T cell therapy, including cytotoxic chemotherapy, lenalidomide, and clinical trials. Biospecific antibodies and their activity in patients like these are also discussed, as well as the potential of molecular tumor characteristics guiding towards specific novel agents or compassionate access programs.